-  First-to-market digital laboratory informatics solution with RFID labels 
  for rapid access to reagent data

-  Improves inventory management; facilitates regulatory compliance; minimizes 
  reagent waste

-  Reduces time on repetitive, error-prone tasks 

Merck, a leading science and technology company, today launched its LANEXO(TM) 
Lab Inventory, Safety and Compliance Management System ( 
https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=2574861931&u=http%3A%2F%2Fwww.sigmaaldrich.com%2FLanexo&a=LANEXO%E2%84%A2+Lab+Inventory%2C+Safety+and+Compliance+Management+System 
), a new digital laboratory informatics solution designed to drastically 
reduce(1) time in labs and improve data quality and traceability. 

Photo - https://mma.prnewswire.com/media/1096823/Merck_LANEXO.jpg

"Today, 85 percent of labs are using paper or Excel to manage consumables data, 
and 25 percent of time is spent managing these data — taking scientists away 
from bench research," said Jean-Charles Wirth, head of Applied Solutions, Life 
Science at Merck. "Lab efficiency is critical as it gives scientists more time 
to focus on their research and analytics work and less on administrative tasks, 
which ultimately leads to faster drug development. Our LANEXO(TM) System — with 
first-to-market features — underscores Merck's commitment to advancing and 
commercializing laboratory informatics." 

Laboratory informatics is the application of data using a platform of software, 
data management tools and equipment that allow scientific data to be captured 
and interpreted for immediate use, and then stored for future research and 
development purposes. The laboratory informatics market, which accounted for 
$2.4 billion in 2018, is expected to reach $5.45 billion by 2027, according to 
a recent Research and Markets global market outlook report ( 
https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=2861032949&u=https%3A%2F%2Fwww.researchandmarkets.com%2Freports%2F4897418%2Flaboratory-informatics-global-market-outlook%3Futm_source%3Ddynamic%26utm_medium%3DBW%26utm_code%3Dbt25ps%26utm_campaign%3D1341235%2B-%2BGlobal%2BLaboratory%2BInformatics%2BMarkets%2BExpected%2Bto%2BGrow%2Bwith%2Ba%2BCAGR%2Bof%2B9.5%2525%2BDuring%2Bthe%2BForecast%2BPeriod%252c%2B2018-2027%26utm_exec%3Danwr281bwd&a=Research+and+Markets+global+market+outlook+report 
).  

Merck is the first to offer radio-frequency identification (RFID) labels which 
auto-register open dates and calculate expiry dates. Through this digital data 
capture, the LANEXO(TM) System rapidly documents lab reagent data in real time. 
Digitalized inventory, expiration and storage monitoring reduces human error 
and safety risks and improves the reliability and traceability of compliance 
documentation. Ultimately, each reagent, including in-house preparations, can 
be instantly matched to a full audit report. Within an experimental workflow, 
the system allows for easy reagent identity checks and provides automatic 
alerts, helping scientists to avoid using expired reagents and minimizing 
experimental error.
 
The cloud-based LANEXO(TM) System can be easily set up and rapidly integrated 
into existing lab workflows. It includes mobile (Android) and web applications 
and is designed for use in highly regulated analytical and research labs in 
pharmaceutical, quality assurance / quality control and industrial testing 
markets.

Merck last year launched Milli-Q(R) Connect ( 
https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=3080595286&u=https%3A%2F%2Fwww.sigmaaldrich.com%2Ftechnical-documents%2Farticles%2Fbiology%2Fwater-purification-systems%2Fafs-e-high-throughput.html&a=Milli-Q%C2%AE+Connect 
), a cloud-based service portal for its water purification systems, and also 
acquired BSSN Software, a lab informatics company that makes data more readily 
accessible for ease of integration, collaboration, analysis and long-term 
archiving. 

Merck unveiled the LANEXO(TM) System during a press conference at the Pittcon 
Conference & Expo 2020 ( 
https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=1602581360&u=http%3A%2F%2Fpittcon.org%2F&a=Pittcon+Conference+%26+Expo+2020 
) in Chicago, Illinois, USA. The system is an expansion of Merck's portfolio of 
digital lab productivity solutions. For more information, visit 
www.SigmaAldrich.com/Lanexo.

All Merck news releases are distributed by email at the same time they become 
available on the Merck website. Please go to www.merckgroup.com/subscribe to 
register online, change your selection or discontinue this service. 

About Merck
Merck, a leading science and technology company, operates across healthcare, 
life science and performance materials. Around 56,000 employees work to make a 
positive difference to millions of people's lives every day by creating more 
joyful and sustainable ways to live. From advancing gene- editing technologies 
and discovering unique ways to treat the most challenging diseases to enabling 
the intelligence of devices – Merck is everywhere. In 2018, Merck generated 
sales of €14.8 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to 
Merck's technological and scientific advances. This is how Merck has thrived 
since its founding in 1668. The founding family remains the majority owner of 
the publicly listed company. Merck holds the global rights to the "Merck" name 
and brand. The only exceptions are the United States and Canada, where the 
business sectors operate as EMD Serono in healthcare, MilliporeSigma in life 
science, and EMD Performance Materials.

(1) Merck estimates that its LANEXO(TM) System provides a 97 percent time 
savings on inventory management and a 92 percent time savings on setting up an 
experiment and documentation.

SOURCE:  Merck

CONTACT: karen.tiano@milliporesigma.com
         Phone: +49-6151-72-44461